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Background: Gender minorities encounter a myriad of barriers to accessing general and gender 
affirming healthcare. Financial disparities impacting affordability of healthcare costs and 
insurance-based denials for gender-affirming care are among prominent barriers discussed. 
Considerations of the prevalence of stigma, discrimination, and erasure of gender minority 
identities must not be neglected when seeking to understand healthcare accessibility and 
utilization in this population. Previous researchers have examined gender minority patients’ 
experiences of discrimination in healthcare settings and delaying care due to fear of 
discrimination. There is a dearth of knowledge about the relationship between lifetime exposure 
to varied forms of healthcare discrimination and healthcare avoidance behaviors; potentially 
resulting in health disparities in this population. The purpose of this study was to examine the 
relationship between perceived lifetime healthcare discrimination and healthcare avoidance in 
the past year and since the start of the coronavirus pandemic due to anticipated discrimination in 
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a gender minority sample. This study also evaluated the relationship between perceived 
healthcare discrimination and anxiety and depressive symptoms in this population. Method: The 
gender minority sample (N = 342) was recruited using an online recruitment platform. 
Participants responded to inquiries related to their demographic information, experiences of 
gender identity-related discrimination in healthcare, healthcare utilization, and mental health 
symptoms. Results: The majority (78.1%) of participants reported being exposed to at least one 
form of healthcare discrimination in their lifetime, though participants reported experiencing an 
average of almost two and a half (M = 2.43) distinct forms of healthcare discrimination. Most 
(64.9%) participants reported that the medical forms that healthcare providers asked them to 
complete were not inclusive of their gender identity at least once in their lifetime and 43.5% 
reported having to teach a healthcare provider about gender minority identities in order to receive 
appropriate healthcare. More than a fourth (26.3%) of participants reported avoiding needed 
healthcare in the past year and 16.1% since the start of the coronavirus pandemic due to 
anticipated discrimination in healthcare settings because of their gender identity. A majority of 
the sample scored at or exceeded the clinical thresholds (³7) on the depression (73%) and 
anxiety (62%) Brief Symptom Inventory subscales. Hierarchical logistic regression analyses 
showed that healthcare discrimination significantly predicted healthcare avoidance in the past 
year, χ2 (1) = 44.14, p < .001, OR = 1.54, 95% CI [1.35-1.75], p < .001, and since the start of the 
coronavirus, χ2 (1) = 36.27, p < .001, OR = 1.55, 95% CI [1.34-1.78], p < .001, over and above 
five demographic variables (age, race, income, insurance coverage, and disability/neurodivergent 
identity status). Participants were 54% more likely to avoid needed healthcare in the past year 
and 55% more likely since the start of the coronavirus as their exposure to distinct types 
healthcare discrimination increased. Healthcare discrimination significantly predicted anxiety, 
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∆R2 = .084, ∆F (1, 338) = 32.17, p < .001, and depressive symptoms, ∆R2 = .044, ∆F (1, 338) = 
16.09, p < .001, over and above two demographic variables (age and race). Discussion: These 
findings suggest that healthcare avoidance incited by exposure to gender identity-based 
healthcare discrimination and erasure is a prominent barrier perceived by transgender and gender 
independent individuals to accessing healthcare generally and during a global pandemic. 
Conclusion: The adoption and implementation of healthcare inclusion initiatives and policies 
would be supportive of increasing equitable access to and utilization of healthcare for 
transgender and gender independent individuals.  
 














The Harm in Seeking Care 
Assessing the Relationship Between Healthcare Discrimination and Healthcare Avoidance 
Behaviors in the Past Year and Since the Start of the Coronavirus Pandemic in a Transgender 
and Gender Independent Sample 
Introduction 
The visibility and prevalence of gender minority individuals has increased in recent 
years, leading to the proliferation of empirical research regarding the biological, psychological, 
and social experiences of this population. Despite their increased visibility in multiple societal 
contexts and in existing health and psychology research literature, gender identity related 
discrimination and marginalization is prevalent in almost every institutional, systematic, and 
social domain that gender minorities engage with, including healthcare settings. Stigma, 
discrimination, and erasure of gender minority identities in healthcare settings serve as central 
barriers in accessibility and utilization of healthcare for gender minority patients (Bauer et al., 
2009; Bauer et al., 2014; Bauer et al., 2015; Bradford et al., 2013; Grant et al., 2011; Jaffee et al., 
2016; James et al., 2016; Macapagal et al., 2016; Puckett et al, 2020; Rodriguez et al., 2017; 
Seelman et al., 2017; Shires & Jaffee, 2015; White et al., 2015). Gender minority patients 
represent a vulnerable tier of health care consumers facing distinct direct and indirect forms of 
discrimination in healthcare settings including healthcare providers’ lack of knowledge about 
gender minority identities and healthcare needs, verbal and physical harassment, abuse, and 
denial of care (Bakko & Kattari, 2020; Cruz, 2014; Grant et al., 2011; James et al., 2016, 
Rodriguez et al., 2017). Several studies have reported that gender minority individuals delay or 
avoid needed healthcare due to fears of discrimination (Cruz, 2014; Grant et al., 2011; Jaffee et 
al., 2016; James et al., 2016; Kattari et al., 2019; Lykens et al., 2018; Seelman et al., 2017; White 
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et al., 2015). To the author’s knowledge, no studies have sought to investigate the culmination of 
various forms of reported lifetime healthcare discrimination as a predictor for healthcare 
avoidance due to anticipated discrimination in gender minority individuals. The aim of the 
present study is to evaluate the relationship between reported lifetime healthcare discrimination 
and healthcare avoidance in the past year and since the start of the coronavirus pandemic due to 
anticipated discrimination among gender minorities. The present study also seeks to evaluate the 
relationship between perceived healthcare discrimination and anxiety and depressive symptoms 
in this population. 
Terminology 
The term gender minority refers to transgender and gender nonconforming individuals 
whose gender identities, gender roles, and gender expressions do not align with or conform to the 
gender norms associated with their natal (birth) sex (Hendricks & Testa, 2012). The terms 
transgender and gender nonconforming (TGNC) are referred to as umbrella terms - this 
terminology is often considered to be inclusive of and used to signify the vast spectrum of 
identities that exist within this community, although not all individuals within this community 
use this terminology to describe their gender identity. In an effort to not reinforce gender 
binarism (i.e., the idea that gender identity must solely and distinctly conform to assigned natal 
sex; Krieger, 2020) and to affirm the wholeness and the internal knowing of gender embodied in 
individuals within this community, I will refer to this population as transgender and gender 
independent for the remainder of this thesis. The term gender independent has been used in 
previous literature regarding this population in Canada (Pyne, 2014) and Australia (Zappa, 
2017). Transgender and gender independent individuals are those who may have been assigned a 
female natal sex and identify more closely with masculinity and seek congruity anatomically and 
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psychologically (FTM), assigned a male natal sex and identify more closely with femininity and 
seek congruity anatomically and psychologically (MTF), and those individuals who were 
assigned a male, female, or intersex natal sex and whose gender identities align with neither, 
both, or an amalgamation of masculinity and femininity who may or may not seek congruity 
anatomically and psychologically (e.g., gender nonbinary, genderqueer, androgynous, neutrois, 
etc.). This range of gender identities and conceptualization of the variance in the relationship 
between natal sex and gender identity varies away from historical constructs regarding gender 
(American Psychological Association, 2015).  
Prevalence of Transgender and Gender Independent Identities 
In a meta-analysis, Meerwijk & Sevelius (2017) examined national population-based 
surveys published from 2006 to 2016 to estimate the population size of transgender individuals 
in the United States. Their study indicated that for every 100,000 adults in the United States that 
390 (0.39%) identify as transgender – equating to almost 1 million Americans (Meerwijk & 
Sevelius, 2017). In a similar analysis of surveys published from 2009 to 2011, with a specific 
focus on the transgender and gender independent population in Massachusetts, it was estimated 
that 0.5% of the adult population surveyed (ages 18 to 64 years) identified as transgender and/or 
gender independent (Conron et al., 2012). These studies depict that there is a significant 
proportion of individuals in the United States population who have a transgender or gender 
independent identity. The prevalence of this population may be much higher than previous 
research has been able to distinguish and articulate due to informational erasure, the prominent 
use of convenience samples, and the methodological reliance on explicit (self-report) survey 
measures or on the identification of individuals in this population from medical charts and 
diagnostic coding within clinical and healthcare settings. Some individuals in this population 
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may be aware of their gender variance and yet do not identify as a transgender (i.e., transgender 
is rarely an option given, but even when it is a choice it may not be representative of an 
individual’s gender identity), some may not seek congruity with their gender identity and their 
anatomy or may not have access to seek the support of medical treatment for congruity and 
gender affirming procedures, and others may not find that being visible or represented in 
healthcare settings and research is liberating or even possible.  
Historical Perspective of Gender Identity  
Historically in the United States, sex (biological structures of what is categorized as male 
or female – sex chromosomes, hormones, and internal and external genitalia identified at birth) 
has been conflated with gender (existing in a role that is girl/woman/female or boy/man/male in 
accordance with socially designated behavior and personality patterns), and gender roles with 
gender expression (presentations of masculinity and femininity through physical expressions, 
clothing, and verbal/physical gestures and behaviors) (American Psychiatric Association, 2013). 
The conflation and assertions of a biological orientation of sex to gender has resulted in a binary 
and cisnormative view of gender identity – that gender identity is uniformly aligned with an 
individual’s assigned natal sex and that all people conceptualize their identities in this manner. 
The APA (2015) defines gender identity as an individual’s “deeply felt, inherent sense of being a 
boy, a man, or male; a girl, a woman, or female or an alternative gender that may or may not 
correspond to a person’s sex assigned at birth or to a person’s primary or secondary sex 
characteristics” (p. 862).  
Gender Dysphoria 
The APA’s (2013) Diagnostic and Statistical Manual of Mental Disorders 5th edition 
(DSM-5) acknowledges the variances that individuals experience in gender identity development 
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and describes the distress that can be associated with gender variance as Gender Dysphoria. 
Gender dysphoria is defined as the distress that is associated with “a marked incongruence 
between one’s experienced/expressed gender and assigned gender” (APA, 2013). The description 
of gender dysphoria acknowledges that transgender and gender independent individuals’ 
experiences of distress that are associated with the incongruence felt between their natal sex and 
gender identity is not stagnant; that the degree of distress that individuals feel may be in some 
degree impacted by the perceptions or misperceptions (i.e., being misgendered) of others 
regarding their gender identity and their autonomy in, access to, and use of social, psychological, 
and/or physical affirmations of their gender identity should they seek it (APA, 2013). The 
development of the diagnosis of gender dysphoria may have provided transgender and gender 
independent individuals a route to affirmation, validation, and the ability to access necessary 
psychological and physical health care and support. However, its inclusion at times has resulted 
in exploitation, stigma, discrimination, and bias that has impacted transgender and gender 
independent patient control and serves as a barrier in transgender and gender independent 
patients’ ability to advocate for themselves and for the relationship they would like to have with 
their minds and bodies (Lev, 2009). Whether or not a transgender or gender independent 
individual has a gender dysphoria diagnosis or seeks provider or insurance approval for gender 
affirming mental or physical health interventions (e.g., therapy, hormone replacement therapy, 
gender affirming surgeries) they should be treated with competent and compassionate care. 
Health care professionals should rely on standards of care such as the World Professional 
Association for Transgender Health’s (WPATH) Standards of Care for the Health of 
Transsexual, Transgender, and Gender Nonconforming people (Coleman et al., 2012) for 
guidance, when their organization does not have inclusive and affirming standards to guide them 
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– rather than continue to perpetuate incompetent, stigmatizing, and discriminatory practices. 
Stigma and discrimination can have an immensely harmful impact on an individual’s health and 
well-being and may result in minority stress (Frost & Meyer, 2009).  
Minority Stress Model 
The Minority Stress Model (Meyer, 2003) - initially formulated to consider the minority 
stress processes of the Lesbian, Gay, and Bisexual population; is facilitative in interpreting why 
transgender and gender independent individuals experience heightened distress. Applications of 
the minority stress model have been applied to the transgender and gender independent 
population (Hendricks & Testa, 2012; Testa et al., 2015). The model examines the three 
processes through which transgender and gender independent individuals are vulnerable to 
socially induced stress; distal stressors, interactive proximal stressors, and internalized proximal 
stressors. Distal stressors are those that are external and observable such as transgender and 
gender independent individuals’ experiences with discriminatory, stigmatized, and violent 
behaviors in multiple societal domains – to include health care settings (e.g., a doctor or nurse 
refusing to use the patient’s preferred pronoun). Interactive proximal stressors are the processes 
by which transgender and gender independent individuals develop a heightened vigilance in 
anticipation and expectation for rejection, discrimination, stigma, and violence (e.g., a 
heightened fear of verbal harassment in a health care setting due to experiencing or witnessing 
verbal harassment in the past). Internalized proximal stressors are demonstrative of the 
psychological processes that occur for transgender and gender independent individuals when 
they internalize the rejection and negative social demeanors that may result in concealment of 
their gender identity, internalized transphobia, detrimental mental health outcomes, inefficacious 
coping strategies such as non-medical use of prescription drugs (Benotsch et al., 2013) or 
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avoidance of needed health care (Bauer et al., 2014; Jaffee et al., 2016; James et al., 2016; 
Macapagal et al., 2016; Seelman et al., 2017). Researchers have assessed various facets of 
minority stress and resilience pathways that may transcend the negative health outcomes that 
exist as a result of socially induced stress such as elevated self-esteem and identity acceptance, 
social support, and advocacy for the reduction and/or elimination of stigmatized and 
discriminatory policies that exist within social systems (Bariola et al., 2015; Barr et al., 2016; 
Meyer, 2015). The minority stress model has been a predominant conceptual framework through 
which researchers have explained the heightened levels of stress and adverse health outcomes 
that transgender and gender independent individuals experience as a result of chronic, complex, 
and high levels of gender identity-related stigma, prejudice, and discrimination (Flentje et al., 
2019; Meyer, 2020).  
Psychological Distress  
A number of empirical studies have articulated noteworthy findings regarding the 
elevated levels of psychological distress reported by transgender and gender independent 
individuals related to experiences of minority stress (e.g., discrimination, stigma, and violence) 
(Barzagan & Galvin, 2012; Bockting et al.., 2013; Clements‐Nolle et al., 2006; Dispenza et al., 
2012; James et al., 2016; Rotondi et al., 2011; Staples et al., 2018; Tebbe & Moradi, 2016; Testa 
et al., 2017, 2015). Exposure to minority stress has been found to be related to a myriad of 
mental health concerns including depression (Barzagan & Galvin, 2012; Bockting et al., 2013; 
Dispenza et al., 2012; Puckett et al., 2019; Puckett et al., 2020; Rotondi et al., 2011), anxiety 
(Bockting et al., 2013; Borgogna et al., 2019; Puckett et al., 2019; Puckett et al.., 2020), and 
suicidality (Clements‐Nolle et al., 2006; Dickey & Budge, 2020; James et al., 2016; Staples et 
al., 2018; Testa et al., 2017). Studies have also explored associations between exposure to 
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discrimination and internalized stigma (Meyer, 2003; Watson et al., 2019); which when 
combined with experiences of external discrimination and violence may result in psychological 
exhaustion, concern for physical and psychological safety, anticipation for future discriminatory 
experiences, and avoidance of spaces that may result in discrimination and/or victimization 
(Puckett et al., 2018; Rood et al., 2016). Though researchers have clearly articulated the 
deleterious psychological distress that transgender and gender independent individuals 
experience driven by their experiences of discrimination, stigmatization, and marginalization; 
less is known about the relationship between experiences of health care discrimination and 
psychological symptoms experienced by this population. The current study aimed to evaluate the 
relationship between perceived health care discrimination and anxiety and depressive symptoms 
in a sample of transgender and gender independent individuals.  
Erasure 
Though direct and visible forms of stigma and discrimination are important to consider 
when examining the ostracism associated with deleterious health outcomes in transgender and 
gender independent individuals, erasure is an additional distinct function that is supportive in 
understanding the intricate systematic, structural, and institutional exclusion that makes this 
population vulnerable in healthcare settings (Bauer et al., 2009). A qualitative analysis conducted 
by Bauer et al (2009) further conceptualized two distinct ways that erasure in healthcare impacts 
transgender and gender independent individuals - informational and institutional erasure. 
Informational erasure refers to the deficit in knowledge advanced about the experiences of 
transgender and gender independent individuals and the assumption that such knowledge does 
not exist, when there is evidence of people who have these identities and experiences (Bauer et 
al., 2009). Informational erasure can also be conceptualized in terms of gender identity data not 
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being routinely collected in population surveys (e.g., The U.S. Census); in contrast, data on natal 
sex is often collected in most population and health surveys. Institutional erasure refers to a lack 
of policy and structure in organizations and systems to at the very least accommodate, protect or 
affirm gender minorities (e.g., public restrooms and accommodations being designated for 
men/women, or medical intake forms that utilize binary framing sex categories). Transgender 
and gender independent individuals’ susceptibility to direct and indirect forms of informational 
and institutional erasure serve as barriers in accessibility and engagement with healthcare (Bauer 
et al., 2009). The current study aimed to understand this population’s experiences of erasure 
when engaging with healthcare providers.  
Healthcare Discrimination 
Existing studies have reported disturbingly high patterns of societal discrimination in 
education, housing, employment, legal protection and support, public accommodations, and 
access to quality healthcare (Grant et al., 2011, James et al., 2016; McCann & Brown, 2017). 
Grant et al (2011) and James et al (2016) identified inequalities in education and employment as 
barriers to healthcare access, amidst the discrimination that transgender and gender independent 
individuals face in healthcare when they are able to access it. Transphobia (i.e., irrational fear 
and/or hatred of transgender and gender independent individuals) and cisgenderism (i.e., 
systemic bias based on the idea that all people are cisgender, thereby leading to prejudicial 
beliefs and behaviors toward transgender and gender independent individuals) contribute to the 
violence and discrimination that transgender and gender independent individuals are exposed to 
in structural systems including education, thereby contributing to the inequities this population 
faces in employment impacting their ability to cover healthcare costs (Grant et al., 2011; James 
et al., 2016). Rodriguez et al (2017) assessed discrimination in health care settings among 
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transgender and gender independent identified individuals (N = 6,106) in the United States 
related to their recognizability as a transgender or gender independent. Almost half (49%) of the 
participants in the study reported that they are always, most of the time, or some of the time 
recognized as a transgender and/or gender independent. Experiences of discrimination in health 
care was reported by 33.1% of the participants. The researchers in the study found that there was 
a significant relationship between being recognized as transgender and/or gender independent to 
any extent and perceived discrimination in healthcare settings, with discrimination being most 
prevalent in participants who reported being recognized as transgender or gender independent 
always (40.9%) and most of the time (36.9%). In a similar study Shires & Jaffee (2015) 
examined the factors associated with health care discrimination against FTM identified 
individuals (N = 1,711) in a secondary analysis of the National Transgender Discrimination 
Survey (Grant et al., 2011). The researchers in the study found that 41.8% of the participants 
reported verbal harassment, physical assault, or denial of equal treatment and care in a doctor’s 
office or hospital. The researchers in the study also found that being a racial/ethnic minority, 
sexual minority, having a lower education level, living in a specified non-binary gender identity, 
using hormonal and surgical treatments, and having identification documents where gender 
identity and natal sex were not aligned was associated with increased reporting of health care 
discrimination experiences. The discrimination and disparities articulated in this study were 
consistent with the findings in James et al.’s (2016) U.S. Transgender Survey findings of high 
levels of mistreatment and discrimination when seeking healthcare among a national sample of 
transgender and gender independent individuals (N = 27, 715). One-third (33%) of the 
participants who engaged with a health care provider had at least one negative experience related 
to being transgender and/or gender independent, with higher negative experiences reported when 
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participants reported intersecting minority identities. Additionally, James et al (2016) reported 
that 33% of participants did not see a health care provider when it was necessary due to their 
inability to afford the care, and 23% of participants reported avoiding health care services when 
it was necessary in the year prior to the completion of the self-report survey. Although 
researchers have described the prevalence of individual forms of healthcare discrimination (e.g., 
refusal or denial of trans-related care) using dichotomous variable responses (e.g., yes or no), to 
the author’s knowledge no studies have evaluated the culmination of varying forms of healthcare 
discrimination across multiple forms of healthcare discriminatory experiences. The current study 
investigated the predictability of mental health outcomes and healthcare avoidance behaviors 
related to perceived healthcare discrimination.  
Healthcare Avoidance 
Researchers have begun to further investigate the avoidance and delaying of engagement 
in needed care due to the prevalence of stigma, discrimination, and erasure of transgender and 
gender independent identities in health care (Bauer et al., 2014; Bauer et al., 2015; Bradford et 
al., 2013; Jaffee et al., 2016; Macapagal et al., 2016; Seelman et al., 2017). Seelman et al (2017) 
examined whether or not non-inclusive healthcare and fear-based delaying or avoiding 
healthcare would predict poorer healthcare outcomes in a sample (N = 417) of transgender and 
gender independent adults in the Rocky Mountain region of the United States. The researchers in 
the study found that participants who delayed healthcare due to their fear of discrimination had 
worse general health than those who did not delay care (B = 0.26, p < .05), and that they were 
also at a 3% greater risk for anxiety and depression symptoms, a 4% greater risk of a past year 
suicide attempt, and 3% greater risk of past year suicidal ideation. In addition to fear of 
discrimination, researchers have also reported avoidance or delays in seeking care due to other 
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factors such as fear of discrimination due to an intersecting sexual minority identity (Macapagal 
et al., 2016), intersecting cultural identities (Bradford et al., 2013), and perceived provider 
sensitivity to and knowledge of transgender and gender independent identities and concerns 
(Bauer et al., 2015; Jaffee et al., 2016). The findings of these studies articulate fear of 
discrimination and consequent avoidance and delay of care as a dominant factor in health care 
challenges faced by transgender and gender independent identities. The current study 
investigated the relationship between perceived healthcare discrimination and avoidance of 
healthcare due to anticipated discrimination in the past year and since the start of the coronavirus 
pandemic.  
The Coronavirus Pandemic 
On March 11, 2020 the World Health Organization (WHO) declared the coronavirus 
outbreak a global pandemic (WHO, 2020). In response to that declaration, U.S. federal and state 
governments began to close or restrict access to public entities and issue guidance to the public 
to mitigate the spread of the coronavirus. The Centers for Disease Control and Prevention (CDC) 
issued guidance to state and local governments, primary and secondary schools, institutions of 
higher education, nursing homes, and individuals to limit community transmission by 
discouraging interaction between individuals outside of their homes, advising individuals to 
practice social distancing when interacting in public spaces, and encouraging the use of face 
coverings when entering indoor spaces (CDC, 2020a, b). In combination with the novelty of the 
coronavirus pandemic and the marginalization of the Lesbian, Gay, Bisexual, Transgender, and 
Questioning (LGBTQ+) community there is a dearth of knowledge regarding the impact that the 
coronavirus has had on the LGBTQ+ population generally. Researchers have highlighted 
potential individual, structural, and social challenges faced by LGBTQ+ populations in the 
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context of the coronavirus pandemic (Salerno et al., 2020). Gonzalez et al (2020) evaluated the 
mental health needs of LGBT college students in the U.S. during the coronavirus pandemic. The 
study found that approximately 60% of the sample (N = 477) reported experiencing 
psychological distress, anxiety, and depression during the pandemic. To the author’s knowledge, 
there have been investigations of the impacts of the coronavirus pandemic on psychological 
health outcomes among individuals in this population (Hawke et al., 2021; Hunt et al., 2021; 
Kidd et al., 2021; Moore et al., 2021), but none have investigated the physiological health 
impacts of the pandemic on transgender and gender independent individuals. The current study 
evaluated the relationship between perceived experiences of healthcare discrimination and 
avoidance of healthcare due to anticipated discrimination since the start of the pandemic. 
The Present Study 
The aim of the present study was to evaluate the relationship between reported lifetime 
healthcare discrimination and healthcare avoidance in the past year and since the start of the 
coronavirus pandemic due to anticipated discrimination among transgender and gender 
independent individuals. Although previous research has examined this population’s experiences 
with discrimination in healthcare settings and delaying healthcare due to fear of discrimination, 
no studies have examined the culmination of varied forms of discrimination as a predictor for 
healthcare avoidance behaviors due to anticipation of discrimination, or psychological distress. 
The present study also evaluated the relationship between perceived healthcare discrimination 
and anxiety and depressive symptoms in this population.  
Hypothesis 1a-1b: I hypothesize that perceived healthcare discrimination will 
significantly predict past year healthcare avoidance due to anticipated discrimination among 
transgender and gender independent individuals. I also hypothesize that perceived healthcare 
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discrimination will significantly predict past year healthcare avoidance due to anticipated 
discrimination after accounting for other factors that may contribute to healthcare avoidance 
behaviors including age, race/ethnicity, income, disability/neurodivergent identity status, and 
health insurance coverage.  
Hypothesis 2a-2b: I hypothesize that perceived healthcare discrimination will 
significantly predict healthcare avoidance since the start of the coronavirus due to anticipated 
discrimination among transgender and gender independent individuals. I also hypothesize that 
perceived healthcare discrimination will significantly predict healthcare avoidance since the start 
of the coronavirus due to anticipated discrimination after accounting for other factors that may 
contribute to healthcare avoidance behaviors including age, race/ethnicity, income, health 
insurance coverage, and disability/neurodivergence identity status; and symptoms of 
coronavirus. 
Hypothesis 3: I hypothesize that perceived healthcare discrimination will significantly 
predict anxiety symptoms after accounting for other factors that may predict anxiety symptoms 
including age and race/ethnicity.  
Hypothesis 4: I hypothesize that perceived healthcare discrimination will significantly 
predict depression symptoms after accounting for other factors that may predict depression 








 The data for this study were derived from participant responses to a survey administered 
online from June 25 to July 4, 2020. The participants were recruited using Prolific, an online 
research participant recruitment platform that connects social, economic, and political science 
researchers with their intended research demographic. Researchers have found that Prolific offers 
a more transparent and protective research environment for participants and researchers, higher 
data quality, and higher levels of participant naivety and diversity when compared with other 
online research recruitment platforms (Palan and Schitter, 2018; Peer et al., 2017). Several steps 
were taken to ensure the quality of the data collected in this online survey: (a) participants had to 
complete prescreening demographic information via their Prolific profile to be considered for the 
study; specifically the information that participants reported regarding their natal sex and current 
gender identity when creating their initial Prolific research participant profile was used to only 
invite those that did not identify as cisgender, (b) IP addresses were examined to ensure that 
participants were in the United States and to support in the identification of any potential 
duplicate responses, (c) the survey platform included survey protection options that allowed the 
participants’ anonymous Prolific IDs to be recorded for support in identifying potential duplicate 
responses, (d) participants were required to accurately complete a CAPTCHA challenge to 
inhibit programmed responses (e.g., participants were prompted to check a box stating “I’m not a 
robot” and accurately identify items within a gridded photo), and (e) participants were required 
to answer five questions positioned within the survey to assess their attention to what survey 
questions were asking of them and had to accurately complete four of the five attention checks to 
be included in study analysis (e.g., Please select “neither agree nor disagree” for this item.). 
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These attention checks were also supportive of disqualifying participants who were being 
potentially impetuous or randomly responding to survey questions.  
Participants were required to meet the following criteria to be eligible to participate in 
this study: (a) be 18 years old or older, (b) identify as transgender or gender independent (e.g., 
Transgender, Gender non-conforming, Non-binary, Genderqueer, Gender fluid, and other gender 
identities that vary away from the historical binary lens of gender), (c) have the ability to 
complete the anonymous self-administered online Prolific survey in English, and (d) have an 
approval rating of 95 percent or above in prior research studies participated in through the 
Prolific platform. In total, 368 individuals accessed the online survey after qualifying to 
participate in the study based on their responses to a Prolific demographic screener 
questionnaire. Ninety-three percent (n = 342) of the individuals who accessed the survey were 
retained for this study’s analyses. The remaining 7% (n = 26) were disqualified from the study as 
a result of a variety of factors: inaccurately responding to the CAPTCHA challenge (n = 7), not 
completing any questions beyond the CAPTCHA challenge (n =5), inaccurately answering more 
than one of the five attention check questions (n = 1), only completing the portion of the survey 
not inclusive of gender identity and natal sex questions (n =2), and reporting what would appear 
to be a cisgender identity – making them ineligible to participate in the study (n = 11).  
Participants were prompted to review a consent document prior to accessing the survey 
(see Appendix A). Once consent was obtained and the CAPTCHA question was accurately 
answered participants were asked to respond to inquiries regarding demographic information, 
experiences of gender-related discrimination in healthcare and in other contexts, healthcare 
engagement or avoidance behaviors, mental health symptoms, resiliency factors, substance use 
behaviors, and coronavirus impacts. In total, the survey consisted of 112 items (survey 
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respondents may have engaged with fewer items due to skip patterns throughout the survey) and 
took participants an average of 13 minutes to complete. Upon completion of the survey 
participants received compensation for their time in the amount of $1.20. The current study’s 
materials and procedures were approved by Virginia Commonwealth University’s Institutional 
Review Board.  
Sample 
The final sample (N = 342) includes transgender and gender independent respondents 
from 42 of the United States of America and the District of Columbia. The predicted population 
for 2019 from the U.S. Census Bureau (2019) was found to be strongly correlated with the 
number of participants from each state, r(49) = .95, p < .001. On average, participants were 25.8 
years old (Standard Deviation = 7.2, Range = 18 – 59 years). The sample reported a diverse 
range of gender identities. Just over half of the sample identified as either Non-binary (39.2%) or 
Trans Man (12.3%), and the other half of the sample reported gender identities including Trans 
Woman, Man, Woman, Gender Fluid, Genderqueer, Gender Non-Conforming, or another 
identity not listed. A total of 32 participants reported that their gender identity was not listed 
among the survey options. Examples of the written responses for those participants included: 
Agender, Bigender, Transmasculine, Transmasculine non-binary, and other individually listed 
identities (e.g., “Demi-boy”, “Demigirl”, “Intersex AFAB Trans Masc Non-binary”). An 
assigned female natal sex was reported by the majority (72.1%) of the sample. Over half of the 
sample reported a sexual orientation that was either Bisexual (33.3%) or Pansexual (22.8%). A 
total of 29 participants reported that their sexual orientation was not listed among the survey 
options. Some examples of the responses participants entered include: Queer, Asexual, and 
Demisexual. The majority of participants identified as Non-Hispanic White (68.7%) with low 
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levels of annual income (57% of participants reported that they earned less than $40,000 per 
year). Slightly less than half of the sample reported that the highest level of formal education 
they attained was High School (43%) or GED (6.4%). Employment status varied among the 
sample with over half of the sample being unemployed (33%) or Students (28.9%). The majority 
of the sample reported having health insurance (80.7%) and were more frequently covered under 
private healthcare plans (67.4%). More than half of participants indicated that they have 
primarily lived with parents/siblings (40.4) or a partner (24.0%) during the past year. Sixty-five 
percent of participants reported that their daily activities are limited in some way due to their 
physical, mental, or emotional health. Just over half of the sample identified as disabled and/or 
neurodivergent (52.6%). Though only a small number of participants (n = 33) reported using 
assistive equipment or technologies (e.g., a mobility device, wheelchair, screen reader, 
captioning software, etc.) this is important to note. A complete description of demographic 
information for the sample is presented in Table 1. 
Table 1: Sample Demographics 
Demographic Characteristics n (%) 
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 Most demographic variables (U.S. state of residence, natal sex, gender identity, sexual 
orientation, race or ethnicity, education, employment status, annual income, and housing status) 
were categorical. Participants were asked to type their age in a designated space. State of 
Residence was assessed by asking participants to select the state they lived in at the time of 
survey completion from a drop-down menu. Assigned natal sex was measured with a question 
asking participants to report their sex identified at birth; participants could choose male or 
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female. Gender identity data were collected by asking participants to select all gender identity 
categories that applied to them. Gender identity categories included man, woman, trans man, 
trans woman, non-binary, genderqueer, gender non-conforming, gender fluid, and another 
identity not listed (participants were prompted to write their gender identity in a text box if they 
reported that their gender identity was not listed). Sexual Orientation was measured by asking 
participants to report the sexual orientation category that best described them; the categories 
included Heterosexual/Straight, Homosexual/Gay, Bisexual, Pansexual, Asexual, and another 
identity not listed (participants were prompted to write their sexual orientation in a text box when 
they reported that their sexual orientation was not listed). Race or Ethnicity data were collected 
by asking participants to select all race/ethnicity categories that applied to them. The Race or 
Ethnicity categories included White, Hispanic/Latino/a, Asian/Asian American, Black/African 
American, Native American, and another identity not listed (participants were prompted to write 
their race/ethnicity in a text box if they reported that their race/ethnicity was not included in 
response choices). A mutually exclusive race/ethnicity variable was created for data analysis 
purposes, consistent with previous research analyses (Kattari et al., 2019). Education Attainment 
was assessed by asking participants to indicate their highest level of formal education. Response 
choices for levels of education were: middle school, high school, GED, vocational school, 
associate’s degree, bachelor’s degree, and graduate degree. Employment Status data was assessed 
by asking participants to select one the following categories: employed full-time, employed part-
time, student, retired, on disability, unemployed, or other employment category not listed 
(participants were prompted to type in their status of employment if it was not listed). Annual 
Income was assessed by asking participants to indicate their household annual income by 
selecting one of six categories: $0-$20,000, $20,001-$40,000, $40,001-$60,000, $60,001-
 29 
$80,000, $80,001-$100,000, and more than $100,000. Housing Status was assessed by asking 
participants to indicate where they have primarily lived since the start of the coronavirus by 
choosing one of the following responses: university housing, alone or in non-university housing, 
with my partner, with friends/roommates, with my parents or siblings, in a shelter or 
experiencing housing instability, or another housing/living arrangement not listed. Health 
Insurance Coverage was measured by asking participants if they had health insurance at the time 
that the survey was being completed by selecting yes or no. Health Insurance Coverage Type 
data were assessed by asking participants who indicated that they have health insurance coverage 
what type (public or private) of health insurance they have. Participants were provided with 
definitions for public and private insurance in an effort to support participants’ abilities to 
distinguish between the two types of health care coverage. Disability/Neurodivergent Identity 
data were collected by asking participants indicate whether or not they identify as disabled 
and/or neurodivergent. Limitations in Daily Activities were measured by asking participants if 
any of their daily activities are limited in any way because of their physical, mental, or emotional 
health. Responses regarding physical limitation included: yes, no, or don’t know. Assistive 
Equipment Usage was measured by asking participants if they use any assistive equipment or 
technologies, such as a mobility device, a wheelchair, a special bed, screen reader, or captioning 
software. Participants indicated whether they used assistive equipment by choosing from three 
response choices: yes, no, or don’t know.  
Healthcare Discrimination 
 A total of six items were adapted from the healthcare experiences portion of the 2015 
U.S. Transgender Survey (James et al., 2016) to assess experiences of healthcare discrimination. 
Items assessed participants’ experiences with varied types of discrimination in healthcare 
 30 
settings and when engaging with healthcare providers including: having to educate a doctor or 
healthcare provider about transgender and/or gender independent people in order to receive 
appropriate care, being denied transgender and/or gender independent care or general health care, 
being asked unnecessary and/or invasive questions regarding gender identity status that was 
unrelated to the care being sought, and being verbally or physically harassed or abused. Two 
additional items were added to assess erasure in healthcare settings. Erasure items assessed 
participants’ experiences with two different forms of erasure in healthcare settings or with 
healthcare providers including: denial of the use of a preferred name or pronoun, and medical 
forms and documents not being inclusive of an individually held gender identity. Response 
choices were adopted from Testa et al’s (2015) Gender Minority Stress and Resilience Measure 
(GMSR) and included: “Never”, “Yes, Before 18”, “Yes, After 18”, and “Yes, In the Past Year”. 
Participants could choose multiple response choices if they experienced a specific type of 
healthcare discrimination at multiple points throughout their lives. Separate summary variables 
were created for childhood healthcare discrimination, past year healthcare discrimination, and 
healthcare discrimination that occurred at any point in an individual’s lifetime. For each of the 
summary variables, the total number of events a participant indicated for each distinct time frame 
(e.g., before age 18, past year, and lifetime) were totaled, yielding scores with a possible range of 
zero to eight for each variable. This measure had adequate internal consistency (a = 0.80) in the 
present sample. 
Healthcare Avoidance 
 A total of two items were adapted from the 2015 U.S. Transgender Survey (James et al., 
2016) to assess healthcare avoidance behaviors in the past year. Three additional items were 
created to assess healthcare avoidance behaviors since the start of the coronavirus pandemic and 
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were modeled after the two items adapted from the 2015 U.S. Transgender Survey. Healthcare 
avoidance items assessed participants healthcare avoidance behaviors in distinct time frames 
(e.g., past year and since the start of the coronavirus) due to various factors (cost, anticipated 
discrimination, and coronavirus exposure). The five healthcare avoidance items included: (1) 
“Was there a time in the past 12 months when you needed to see a doctor but could not, because 
of cost?”, (2) “Was there a time in the past 12 months when you needed to see a doctor but did 
not, because you thought you would be disrespected or mistreated as a trans/gender non-
conforming person?”, (3) “Since the start of the coronavirus pandemic (March 11, 2020), was 
there a time when you needed to see a doctor but could not, because of cost?”, (4) “Was there a 
time since the start of the coronavirus pandemic when you needed to see a doctor but did not, 
because you thought you would be disrespected or mistreated as a trans/gender non-conforming 
person?”, (5) “Was there a time since the start of the coronavirus pandemic, when you needed to 
see a doctor but did not, because you were worried about being exposed to the coronavirus in a 
healthcare setting?”. Participants could select “yes” or “no” to indicate whether or not they had 
avoided healthcare in the past year and/or since the coronavirus due to anticipated healthcare 
cost, anticipated discrimination, and/or fear of coronavirus exposure. 
Mental Health Symptoms 
 A total of twelve items from the Depression (six items) and Anxiety (six items) subscales 
of the Brief Symptom Inventory (BSI; Derogatis, 2001) were used to assess symptoms of 
depression and anxiety that occurred over the past week. Participants were asked to rate each of 
the twelve items on a 5-point Likert scale, ranging from “not at all” (0) to “extremely” (4) to 
indicate their experiences over that past seven days. Separate variables for anxiety and 
depression symptoms experienced over the past week were created. The items for each subscale 
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were summed for a total score, yielding scores with a possible range of zero to twenty-four for 
each scale. There was adequate internal consistency for both the Anxiety (a = 0.89) and 
Depression (a = 0.88) subscales in the present sample. 
Coronavirus Health-Related Questions 
 Two items were adapted from Wang et al (2020) to assess whether participants had been 
diagnosed with coronavirus by a healthcare provider or if participants had experienced 
coronavirus symptoms. The two coronavirus health-related questions included: (1) “Have you 
been told by a healthcare provider that you had the coronavirus (covid-19)?”, and (2) “Have you 
had symptoms that might have been the coronavirus (covid-19) such as fever, cough, sore throat, 
difficulty breathing, or loss of smell in the past 3 months, but you weren’t tested?”. Participants 
who indicated that they had not been diagnosed with coronavirus by a healthcare provider were 
given the question regarding having experienced coronavirus symptoms. Participants could 
choose “yes” or “no” to indicate whether or not they had been diagnosed with coronavirus or 
experienced symptoms of coronavirus, but had not been tested. The complete measure can be 












 Data were examined for missing responses for all variables mentioned in the analyses 
herein. It should be noted that there was one participant with missing data on the first two items 
of the Health Discrimination measure. With the exception of the case mentioned, data from the 
full sample were available for analysis for all variables. Preliminary analyses and appropriate 
regression assumption checks indicated that all normality, univariate and multivariate outlier, 
linearity, homoscedasticity, and multicollinearity assumptions were met. Data analyses included 
descriptive statistics, two logistic regression models, and two multiple regression models.  
Hypothesis 1a -1b 
 A direct logistic regression analysis was performed to assess whether perceived 
healthcare discrimination significantly predicts past year healthcare avoidance due to anticipated 
discrimination among transgender and gender independent individuals. A hierarchical logistic 
regression analysis was conducted to assess whether perceived healthcare discrimination 
significantly predicts past year healthcare avoidance due to anticipated discrimination when 
controlling for certain demographic factors. Demographic information including: age, race, 
income, insurance coverage, and disability/neurodivergence identity status were entered into the 
first step, followed by the lifetime healthcare discrimination variable in the final step of the 
model in order to demonstrate that healthcare discrimination can significantly predict past year 
healthcare avoidance due to anticipated discrimination above and beyond the demographic 




Hypothesis 2a – 2b 
 A direct logistic regression analysis was conducted to assess whether perceived 
healthcare discrimination significantly predicts healthcare avoidance since the start of the 
coronavirus pandemic due to anticipated discrimination among transgender and gender 
independent individuals. A hierarchical logistic regression analysis was conducted to assess 
whether perceived healthcare discrimination significantly predicts healthcare avoidance since the 
start of the coronavirus pandemic due to anticipated discrimination when controlling for certain 
demographic factors. Demographic information including: age, race, income, insurance 
coverage, and disability/neurodivergence identity status were entered into the first step of the 
model, followed by lifetime healthcare discrimination variable entered in the final step of the 
model in order to demonstrate that healthcare discrimination can significantly predict healthcare 
avoidance due to anticipated discrimination since the start of the coronavirus pandemic above 
and beyond the demographic factors included in the analysis.  
Hypothesis 3 
 A hierarchical multiple regression was computed to assess whether perceived healthcare 
discrimination significantly predicts anxiety symptoms when controlling for certain demographic 
factors among transgender and gender independent individuals. Demographic information 
including age and race were entered into the first step, followed by the lifetime healthcare 
discrimination variable entered into the final step of the model to demonstrate that healthcare 
discrimination can significantly predict anxiety symptoms above and beyond age and race.  
Hypothesis 4 
A hierarchical multiple regression was computed to assess whether perceived healthcare 
discrimination significantly predicts depression symptoms when controlling for certain 
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demographic factors among transgender and gender independent individuals. Demographic 
information including age and race were entered into the first step, followed by the lifetime 
healthcare discrimination variable entered into the final step of the model to demonstrate that 
healthcare discrimination can significantly predict depression symptoms above and beyond age 






















 The degree to which transgender and gender independent participants reported 
experiencing discrimination in healthcare settings throughout the lifespan varied across specific 
healthcare discrimination items, though the majority (78.1%) of the sample reported 
experiencing at least one of the eight forms of healthcare discrimination that this study examined 
in their lifetime; with an overall sample average of almost two and a half (M = 2.43) distinct 
forms of healthcare discrimination being reported by participants. At least once in their lifetime, 
most (64.9%) participants reported that the medical forms that a doctor or other healthcare 
provider asked them to complete were not inclusive of their gender identity, 42.5% reported that 
they had to teach a doctor or other healthcare provider about transgender and gender independent 
identities so that they could receive the appropriate healthcare, 35.7% reported that a doctor or 
other healthcare provider refused to use the pronouns or name that they requested to be used 
when they were referred to, and 32.7% reported being asked unnecessary and/or invasive 
questions about their transgender or gender independent status that were not related to the reason 
for their visit. The participants who reported that they had not been exposed to healthcare 
discrimination throughout their lifetime represented a minority proportion (21.9%) of the sample. 
The complete results for the eight items of the of lifetime healthcare discrimination variable can 
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N = 73 
 
21.4% 
A doctor or other health 
care provider refused to 
give me other health care 
(such as physical exam, 
flu, diabetes). 
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9.1% 
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trans/gender non-
conforming status that 
were not related to the 
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N = 112 
 
32.7% 
A doctor or other health 
care provider used harsh 
or abusive language 
when treating me. 
 
















N = 61 
 
17.8% 
I was verbally harassed 
in a health care setting 
(such as hospital, office, 
clinic). 
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19.0% 
A doctor or other health 
care provider refused to 
use the pronouns or name 
that I requested to be 
used. 
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 Reported healthcare avoidance in the past year and since the start of the coronavirus 
pandemic varied across rationales for avoidance of needed healthcare (i.e., cost, anticipated 
discrimination, and fear of coronavirus exposure). Avoidance of needed healthcare due to 
healthcare costs in the past year was reported by just under half (46.8%) of participants, and 
healthcare avoidance since the start of the coronavirus pandemic was reported by 30.1% of 
participants. Over a quarter (26.3%) of participants reported avoiding needed healthcare in the 
past year and 16.1% since the start of the coronavirus pandemic due to anticipated discrimination 
in healthcare settings because of their transgender or gender independent identity. A third 
(36.3%) of participants reported avoiding needed healthcare since the start of the coronavirus 
pandemic due to fears of coronavirus exposure in a healthcare setting. The complete results for 
the healthcare avoidance variable can be found in table 3.  
Table 3: Healthcare Avoidance  
Healthcare Avoidance Items: Yes No 
 
Was there a time in the past 12 months 
when you needed to see a doctor but 
could not because of cost?  
 




N = 182 
 
53.2% 
Was there a time in the past 12 months 
when you needed to see a doctor but did 
not because you thought you would be 
disrespected or mistreated as a 
trans/gender non-conforming person? 
 




N = 252 
 
73.7% 
Since the start of the coronavirus 
pandemic (March 11, 2020), was there a 
 
N = 103 
 
N = 239 
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time when you needed to see a doctor but 





Was there a time since the start of the 
coronavirus pandemic when you needed 
to see a doctor but did not because you 
thought you would be disrespected or 
mistreated as a trans/gender non-
conforming person?  
 




N = 287 
 
83.9% 
Was there a time since the start of the 
coronavirus pandemic, when you needed 
to see a doctor but did not because you 
were worried about being exposed to the 
coronavirus in a health care setting? 
 








Mental Health Symptoms 
 Predominately, the sample reported moderately high levels of depressive (M = 10.85, SD 
= 5.97) and anxiety symptoms (M = 8.97, SD = 5.65) based on their scores on the BSI depression 
and anxiety subscales (Derogatis, 2001). The majority (73%) of participants scored at or above 
the clinical threshold on the depression subscale. Over half (62%) of participants scored at or 
above the clinical threshold (³7) on the anxiety subscale.  
Coronavirus Health-Related Questions 
 The majority (99.1%) of the sample reported that they had not been diagnosed with the 
coronavirus by a healthcare provider, while .9% (n = 3) participants reported having been told by 
a healthcare provider that they had the coronavirus. A fourth (25.4%) of the participants (n = 
339) who reported that they had not been diagnosed with the coronavirus reported that they had 
experienced symptoms that might have been the coronavirus in the three months prior to 
participating in the study (e.g., fever, cough, sore throat, difficulty breathing, or loss of smell), 
but had not been tested for the coronavirus. The majority (74.6%) of participants who reported 
that they had not been diagnosed with the coronavirus reported that they had not experienced 
symptoms that might have been the coronavirus. 
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Hypothesis 1a-1b: Past Year Healthcare Avoidance Analyses 
 A direct logistic regression analysis was conducted to assess whether perceived 
healthcare discrimination significantly predicted past year healthcare avoidance due to 
anticipated discrimination among the transgender and gender independent sample. A test of the 
full model against a constant only model was significant, c2(1, N = 342) = 54.69, p < .001, 
Nagelkerke R2 = .22; indicating that healthcare discrimination as a sole predictor reliably 
distinguished between participants who did and did not avoid healthcare in the past year. 
According to Wald’s criterion, healthcare discrimination was further affirmed as a significant 
predictor of past year healthcare avoidance due to anticipated discrimination, c2(1) = 46.67, p < 
.001. The change in odds associated with a one-unit change in score on the healthcare 
discrimination measure was 1.52 (95% CI = 1.35-1.71), indicating that higher exposure to 
healthcare discrimination was associated with a 52% increase in the likelihood of past year 
healthcare avoidance.  
 A hierarchical logistic regression analysis (see table 4) was conducted to assess whether 
perceived healthcare discrimination significantly predicted past year healthcare avoidance due to 
anticipated discrimination when controlling for five demographic factors. Demographic 
information including: age, race, income, insurance coverage, and disability/neurodivergence 
identity status were entered into the first step of the model, followed by the lifetime healthcare 
discrimination variable entered in the final step of the model. When the five demographic 
variables were entered into the model and tested against the constant only model, they 
significantly predicted past year healthcare avoidance, χ2 (5) = 13.39 p = .02, Nagelkerke R2 = 
.056, accounting for 5.6% of the variance. At the initial step of the model, 
disability/neurodivergence identity status was a significant independent predictor of past year 
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healthcare avoidance χ2 (1) = 8.46, p = .004, OR = 2.13, 95% CI [1.28-3.54]. When the 
healthcare discrimination variable was entered into the model a test of the full model against the 
constant only model significantly improved prediction of past year healthcare avoidance, χ2 (6) = 
65.01, p < .001, Nagelkerke R2 = .25, indicating that together age, race, income, insurance 
coverage, disability/neurodivergent identity status, and healthcare discrimination reliably 
distinguished between those who did or did not avoid needed healthcare in the past year, 
accounting for 25% of the variance. Healthcare discrimination, χ2 (1) = 44.14, p < .001, OR = 
1.54, 95% CI [1.35-1.75], p < .001, significantly predicted healthcare avoidance in the past year 
over and above the five demographic variables. For each one point increase in healthcare 
discrimination exposure, participants were 54% more likely to avoid needed healthcare in the 
past year due to anticipating discrimination.  
Table 4: Past Year Healthcare Avoidance 
Variable & Step OR CI B S.E. p 
Step 1: 
    Age 
    Race 
    Income 
    Health Insurance 











































N = 342, ns = not significant 
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Hypothesis 2a-2b: Healthcare Avoidance Since the Start of the Coronavirus Analyses 
 A direct logistic regression analysis was conducted to assess whether perceived 
healthcare discrimination significantly predicted healthcare avoidance since the start of the 
coronavirus pandemic due to anticipated discrimination. A test of the full model against a 
constant only model was significant, c2(1, N = 342) = 46.73, p < .001, Nagelkerke R2 = .22; 
indicating that healthcare discrimination as a sole predictor reliably distinguished between 
participants who did and did not avoid needed healthcare since the start of the coronavirus 
pandemic due to anticipated discrimination. According to Wald’s criterion, healthcare 
discrimination was further affirmed as a significant predictor of healthcare avoidance since the 
start of the coronavirus pandemic due to anticipated discrimination, c2(1) = 41.14, p < .001. The 
change in odds associated with a one-unit change in score on the healthcare discrimination 
measure was 1.55, 95% CI = [1.36-1.78], indicating that higher exposure to healthcare 
discrimination increased the likelihood of healthcare avoidance since the start of the coronavirus 
pandemic by 55%. 
 A hierarchical logistic regression analysis (see table 5) was conducted to assess whether 
perceived healthcare discrimination significantly predicted healthcare avoidance since the start of 
the coronavirus pandemic due to anticipated discrimination when controlling for five 
demographic factors. Demographic information including: age, race, income, insurance 
coverage, and disability/neurodivergence identity status were entered into the first step of the 
model, followed by the lifetime healthcare discrimination variable entered in the final step of the 
model. When the five demographic variables were entered into the model and tested against the 
constant only model, they significantly predicted healthcare avoidance since the start of the 
coronavirus, χ2 (5) = 14.98, p = .01 Nagelkerke R2 = .07. At the initial step of the model 
 43 
disability/neurodivergent identity χ2 (1) = 9.58, p < .002, OR = 2.77, 95% CI [1.45-5.28] was a 
significant individual predictor of healthcare avoidance since the start of the coronavirus 
pandemic. When the healthcare discrimination variable was entered into the model a test of the 
full model against the constant only model significantly improved prediction of healthcare 
avoidance since the start of the coronavirus pandemic, χ2 (6) = 55.68, p < .001, Nagelkerke R2 = 
.26, indicating that together age, race, income, insurance coverage, disability/neurodivergent 
status, and healthcare discrimination reliably distinguished between those who did or did not 
avoid needed healthcare since the start of the coronavirus pandemic, accounting for 26% of the 
variance (accounting for 19% more in variance than the first step of the model). Healthcare 
discrimination, χ2 (1) = 36.27, p < .001, OR = 1.55, 95% CI [1.34-1.78], p < .001, significantly 
predicted healthcare avoidance since the start of the coronavirus pandemic over and above the 
five demographic variables. For each one point increase on the healthcare discrimination 
measure, participants were 55% more likely to avoid needed healthcare since the start of the 
coronavirus pandemic. Having a disability/neurodivergent identity χ2 (1) = 3.90, p = .048, OR = 
2.01, 95% CI [1.01-4.04] decreased in its significance as an independent predictor of healthcare 
avoidance since the start of the coronavirus pandemic due to anticipated healthcare 
discrimination at this step. 
Table 5: Healthcare Avoidance Since Start of the Coronavirus   
Variable & Step OR CI B S.E. p 
Step 1: 
    Age 
    Race 
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N = 342, ns = not significant 
Hypothesis 3: Anxiety Symptoms Analysis 
 A hierarchical multiple linear regression analysis (see table 6) was conducted to assess 
whether perceived healthcare discrimination significantly predicted anxiety symptoms when 
controlling for two demographic factors. Demographic information including age and race were 
entered into the first step of the model, followed by lifetime healthcare discrimination entered in 
the final step of the model. When age and race were entered into the model, they significantly 
predicted anxiety symptoms, F(2, 339) = 5.34 p = .005, R2 = .031. This initial model shows that 
only 3.1% of reported anxiety symptoms could be predicted by knowing a participant’s age or 
race. Older participants reported fewer anxiety symptoms, compared with younger participants. 
Compared to Non-Hispanic white participants, People of Color scored 1.28 points lower, on 
average, in anxiety symptoms than Non-Hispanic whites. When the healthcare discrimination 
variable was added to the model, it significantly improved the prediction of anxiety symptoms 
over and above the two demographic variables, ∆R2 = .084, ∆F(1, 338) = 32.17, p < .001. All 
variables together significantly predicted anxiety symptoms, F(3, 338) = 14.61, p < .001, R2 = 
.115. The final model shows that 11.5% of the variance in reported anxiety symptoms could be 
predicted by knowing an individual’s age, race, and lifetime healthcare discrimination exposure. 
Healthcare discrimination (B = .745, t(338) = 5.67, p < .001) significantly predicted anxiety 
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symptoms over and above age and race. For every one unit change on the healthcare 
discrimination measure, a participants depression score increased by .75. 
Table 6: Anxiety Symptoms  
Variable & Step R2 R2 Change B S.E t 
Step 1:  
    Age 
    Race 










    Healthcare Discrimination 






N = 342, *p <.05; **p <.01; ***p < .001 
Hypothesis 4: Depressive Symptoms Analysis 
 A hierarchical multiple regression analysis (see table 7) was conducted to assess whether 
perceived healthcare discrimination significantly predicted depressive symptoms when 
controlling for two demographic factors. Demographic information including age and race were 
entered into the first step of the model, followed by the lifetime healthcare discrimination entered 
in the final step of the model. When age and race were entered into the model, they significantly 
predicted depressive symptoms, F(2, 339) = 6.91, p = .001, R2 = .039. This initial model shows 
that only 3.9% in reported depressive symptoms could be predicted by knowing a participant’s 
age or race. Older participants reported fewer depressive symptoms, compared with younger 
participants. Compared to Non-Hispanic white participants, People of Color scored .30 points 
lower, on average, in depressive symptoms than Non-Hispanic whites. When the healthcare 
discrimination variable was added to the model, it significantly improved the prediction of 
depressive symptoms over and above the two demographic variables, ∆R2 = .044, ∆F(1, 338) = 
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16.09, p < .001. All variables together significantly predicted depressive symptoms, F(3, 338) = 
10.17, p < .001, R2 = .083. The final model shows that 8.3% of the variance in reported 
depressive symptoms could be predicted by knowing an individual’s age, race, and lifetime 
healthcare discrimination exposure. Healthcare discrimination (B = .567, t(338) = 4.01, p < .001) 
significantly predicted depressive symptoms over and above age and race. For every one unit 
change on the healthcare discrimination measure, a participants depression score increased by 
.57. In this step of the model, age (B = .-.185, t(338) = -4.21, p < .001) was a significant 
individual predictor of depressive symptoms, while race (B= -.486, t(338) = -.714, p = .475) was 
not a significant individual predictor.  
Table 7: Depressive Symptoms 
Variable & Step R2 R2 Change B S.E. t 
Step 1:  
    Age 
    Race 










    Healthcare Discrimination 






N = 342, , *p <.05; **p <.01; ***p < .001 
Exploratory Analyses: The potentiality of Disability/Neurodivergent Status as a Moderator 
 An exploratory hierarchical logistic regression moderation analysis was conducted to 
evaluate the influence of disability/neurodivergent status on the relationship between perceived 
healthcare discrimination and past year healthcare avoidance due to anticipated discrimination. 
Prior to analyses, the independent (healthcare discrimination) and moderation 
(disability/neurodivergent status) variables were centered and a product term was created as 
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recommended by Baron & Kenny (1986). Perceived healthcare discrimination significantly 
predicted past year healthcare avoidance due to anticipated discrimination, χ2 (1) = 42.85, p < 
.001, OR = 1.51, 95% CI [1.33-1.71]. Disability/neurodivergent identity status, χ2 (1) = 2.96, p = 
.085, OR = 1.65, 95% CI [.93-2.92] did not significantly predict past year healthcare avoidance 
due to anticipated discrimination. The association between perceived healthcare discrimination 
and past year healthcare avoidance due to anticipated discrimination was not moderated by 
disability/neurodivergent status, χ2 (1) = .86, p = .353, OR = .89, 95% CI [.69-1.14]. 
 An exploratory hierarchical logistic regression moderation analysis was conducted to 
evaluate the influence of disability/neurodivergent status on the relationship between perceived 
healthcare discrimination and healthcare avoidance since the start of the coronavirus pandemic 
due to anticipated discrimination. Prior to analyses, the independent (healthcare discrimination) 
and moderation (disability/neurodivergent status) variables were centered and a product term 
was created as recommended by Baron & Kenny (1986). Perceived healthcare discrimination, χ2 
(1) = 35.36, p < .001, OR = 1.53, 95% CI [1.33-1.76] and disability/neurodivergent identity 
status, χ2 (1) = 3.95, p = .047, OR = 2.19, 95% CI [1.01-4.73] significantly predicted healthcare 
avoidance since the start of the coronavirus pandemic due to anticipated discrimination. The 
association between perceived healthcare discrimination and healthcare avoidance since the start 
of the coronavirus pandemic due to anticipated discrimination was not moderated by 
disability/neurodivergent status, χ2 (1) = .02, p = .900, OR = .98, 95% CI [.74-1.30]. 
Discussion 
The aim of this study was to evaluate the relationship between lifetime exposure to varied 
forms of healthcare discrimination and four variables: (1) healthcare avoidance behaviors in the 
past year due to anticipated discrimination, (2) healthcare avoidance behaviors since the start of 
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the coronavirus pandemic due to anticipated discrimination, (3) anxiety symptoms, and (4) 
depressive symptoms in a transgender and gender independent sample. Consistent with prior 
research that has conveyed prevalence estimates of the barriers that exist for the transgender and 
gender independent population in accessing healthcare, (Grant et al., 2011; James et al., 2016; 
Macapagal et al., 2016; Rodriguez et al., 2017; Shires & Jaffee, 2015) the results of this study 
make apparent the pervasiveness of exposure to healthcare discrimination and convey its 
deleterious relationship with psychological health and healthcare engagement behaviors in this 
population. The majority (78.1%) of participants reported experiencing at least one of the eight 
forms of healthcare discrimination that this study examined in their lifetime. 
The results of this study reveal the lifetime exposure to various forms of discrimination in 
healthcare settings that is endemic to the transgender and gender independent individual’s 
experience. Specifically, this study provides evidence of the direct (e.g., refusal of care) and 
indirect (e.g., non-inclusive medical forms and/or unnecessary and invasive questions) forms of 
healthcare discrimination that this population is exposed to. Exposure to healthcare 
discrimination might diminish the trust in healthcare institutions and providers that may be 
imperative to patient engagement in care (e.g., preventative care), patient trust in provider 
recommendations (e.g., vaccinations), and improving patient health outcomes (e.g., disease 
management). To seek or require healthcare involves psychological and physical vulnerability, 
as individuals seek care when they are incapable of providing care for themselves. Although 
individuals seek healthcare for a myriad of reasons (e.g., illness prevention, disease management, 
physical trauma and injury, psychological support, etc.), common reasons why individuals might 
seek or require healthcare are solace and healing.  
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The results of this study provide evidence of transgender and gender independent patients 
experiences in healthcare settings that may have the potential to be physically and 
psychologically harmful. This is evident in the participants’ reporting of medical forms not being 
inclusive of their gender identity (64.9%) at least once in their lifetime. Medical forms are often 
the first form of communication that a patient is given to convey their identities, past illnesses, 
diagnoses, health behaviors, etc. If a patient’s gender identity is not included on medical forms, 
this may potentially result in a patient’s negative appraisal of their belongingness in healthcare 
settings. The exclusion of transgender and gender independent individuals’ identities on medical 
forms and records may be associated with the lack of knowledge that healthcare providers have 
about these patients, their intersecting identities, and their health behaviors. This may explain 
why 42.5% of the participants reported having to teach a healthcare provider about transgender 
and gender independent people in order to receive appropriate care at least once in their lifetime. 
Although participants who reported harsh or abusive language (17.8%) being used by a 
healthcare provider, and/or that they were harassed in a healthcare setting (19%) represented the 
minority of the sample, this form of discrimination would be considered to be profoundly 
harmful to encounter in any setting – but especially in a healthcare setting. In addition to 
engagement in healthcare avoidance behaviors, transgender and gender independent individuals 
may conceal their gender identities to avoid the discrimination they anticipate encountering in 
healthcare settings, which has healthcare accessibility (e.g., STI testing, gender affirming care, 
etc.) and outcome (e.g., receiving inappropriate care) implications (Bauer et al., 2009; Cruz, 
2014). 
The results of this study substantiate Hypothesis 1a-1b, which predicted that perceived 
healthcare discrimination would significantly predict past year healthcare avoidance due to 
 50 
anticipated discrimination after accounting for other factors that might impact healthcare 
avoidance behaviors (e.g., age, race/ethnicity, income, disability/neurodivergent status, and 
health insurance coverage). More concretely, independent of an individual’s age, race/ethnicity, 
income level, disability/neurodivergent identity, and/or whether or not they have health 
insurance coverage, their lifetime exposure to healthcare discrimination predicted avoiding 
needed healthcare in the past year when they anticipated encountering gender identity-based 
discrimination. Findings indicate that higher levels of lifetime exposure to varied forms of 
healthcare discrimination significantly increases the likelihood that transgender and gender 
independent individuals will avoid needed healthcare due to anticipation of gender identity-based 
discrimination in healthcare settings. Although the prevalence of exposure to healthcare 
discrimination and its relationship to healthcare avoidance behaviors have been well documented 
(Bauer et al., 2014; Bauer et al., 2015; Bradford et al., 2013; Jaffee et al., 2016; Macapagal et al., 
2016; Seelman et al., 2017), these results empirically advance the knowledge about the harmful 
impacts that exposure to healthcare discrimination has on this population. This study evaluated 
healthcare avoidance behaviors due to anticipation of discrimination based on eight forms of 
healthcare discrimination encountered at least once in the lifetime of participants. This 
knowledge makes apparent the considerable toll that healthcare discrimination has on 
transgender and gender independent individuals in instances when they must consider the 
potential risks of seeking or avoiding varied forms of healthcare beyond gender affirming care 
(e.g., preventative, chronic disease management, gynecological and reproductive, etc.) when it is 
needed. Healthcare avoidance behaviors have been found to have adverse impacts on the 
physical and psychological health of transgender and gender independent individuals (Seelman 
et al., 2017). Individuals who delay or avoid seeking healthcare may experience health disparities 
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that contribute to morbidity and mortality. In particular, associations between delaying needed 
healthcare and delays in cancer diagnosis (Céspedes et al., 2020; Langlands et al., 2002), cancer 
prognosis (Zhang et al., 2015), and early mortality in cancer patients (Biagi et al, 2011; Hanna et 
al., 2020; Raphael et al., 2016) have been documented. The disparities in rates of morbidities and 
disabilities reported by transgender and gender independent individuals compared to cisgender 
individuals (Fredriksen-Goldsen et al., 2014; Witten, 2014) may be related to health avoidance 
behaviors and/or the discrimination they are exposed to in healthcare settings.   
 The results of this study support Hypothesis 2a-2b, which predicted that perceived 
healthcare discrimination would significantly predict healthcare avoidance behaviors since the 
start of the coronavirus due to anticipated discrimination after accounting for other factors that 
might impact healthcare avoidance behaviors (e.g., age, race/ethnicity, income, 
disability/neurodivergent status, and health insurance coverage). More explicitly, independent of 
an individual’s age, race/ethnicity, income level, disability/neurodivergent identity, and/or 
whether or not they have health insurance coverage, their lifetime exposure to healthcare 
discrimination predicted avoiding needed healthcare since the start of the coronavirus when they 
anticipated encountering discrimination based on their gender identity. The results of the 
analyses performed to test this hypothesis indicate that higher levels of lifetime exposure to 
varied forms of healthcare discrimination are significantly associated with an increase in the 
likelihood that transgender and gender independent individuals will avoid needed healthcare 
even during a global pandemic due to anticipation of gender identity-based discrimination in 
healthcare settings. As previously noted, prior research has documented the prevalence of 
exposure to healthcare discrimination and its relationship to healthcare avoidance behaviors; 
these results empirically advance the knowledge about the harmful impacts that lifetime 
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exposure to healthcare discrimination has on this population by evaluating the healthcare 
avoidance behaviors since the start of the coronavirus due to anticipation of discrimination based 
on the culmination of varied forms of healthcare discrimination. This knowledge demonstrates 
that discriminatory encounters in healthcare settings in addition to the anticipation for similar 
encounters is associated with transgender and gender independent patients’ appraisal of their 
access to varied types of care including being tested and/or treated for the coronavirus when 
symptoms are present, or when they have been exposed to someone who has tested positive for 
the coronavirus. Healthcare avoidance is predominately viewed as a behavior that involves risk 
at an individual level, but avoiding needed healthcare (e.g., being tested and/or treated for the 
coronavirus, getting a vaccine in an attempt to mitigate the spread of the coronavirus, etc.) 
presents a public health concern during a global pandemic. 
The results of this study substantiate Hypotheses 3 and 4, which predicted that perceived 
healthcare discrimination would be significantly associated with anxiety and depressive 
symptoms after accounting for other factors that might predict anxiety symptoms including age 
and race/ethnicity. More explicitly, independent of an individual’s age and/or race/ethnicity, their 
lifetime exposure to healthcare discrimination is a stronger predictor of their anxiety and 
depressive symptoms. These results indicate that higher levels of lifetime exposure to varied 
forms of healthcare discrimination is significantly associated with an increase in anxiety and 
depressive symptoms in transgender and gender independent individuals. Although previous 
research has articulated the elevated levels of psychological distress reported by this population 
related to discrimination (Barzagan & Galvin, 2012; Bockting et al.., 2013; Clements‐Nolle et 
al., 2006; Dispenza et al., 2012; James et al., 2016; Rotondi et al., 2011; Staples et al., 2018; 
Tebbe & Moradi, 2016; Testa et al., 2017, 2015), these results empirically advance the 
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knowledge about the harmful relationship between lifetime exposure to varied forms of 
healthcare discrimination and this population’s psychological health.  
Implications for Clinical Practice 
 These findings have significant implications for clinical practice. The centrality of 
healthcare discrimination in transgender and gender independent individuals’ healthcare 
avoidance behaviors, elevated rates of disabilities, morbidities, and psychological distress can be 
nullified. Healthcare discrimination is not only a malleable barrier to this population’s access to 
healthcare and/or the quality of the care they are able to receive, it also contradicts the ethical 
principles that healthcare professionals subscribe to. The American Medical Association (AMA; 
2016) has adopted nine “Principles of Medical Ethics” that serve to be standards of honorable 
conduct for healthcare professionals. The AMA’s (2016) principles hold that healthcare 
professionals have an ethical imperative not limited to seeking advancements in science and 
medical education, but also to providing access to competent medical care that is encompassing 
of human dignity to “all people”. Although, healthcare professionals are obligated to follow 
laws, they are also encouraged to “recognize a responsibility to seek changes in those 
requirements which are contrary to the best interests of the patient” (AMA, 2016).  Healthcare 
providers who engage and/or are complicit in the eight forms of direct or indirect healthcare 
discrimination that this study evaluated are in direct violation of such principles.  
The adoption of several healthcare initiatives aiming to improve healthcare accessibility 
for transgender and gender independent individuals may serve to mitigate the harmful impacts 
associated with the insidious messages that convey disregard for the health of these individuals. 
Healthcare institutions and providers can ensure that the barriers of transphobia and 
cisnormativity are replaced with a conceptualization of gender as a nonbinary construct. It is 
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imperative that healthcare providers attend to their individual appraisals and biases about gender 
identity and expression, as such biases and appraisal may impact the quality of care they provide 
to transgender and gender independent patients. Healthcare institutions have an obligation to 
ensure that whether or not providers value cultural humility (Patallo, 2019), that any knowledge 
deficits related to the healthcare needs of transgender and gender independent patients are 
attended to. Healthcare institutions can ensure that the entirety of healthcare teams (e.g., intake 
staff, billing staff, and providers) are provided with the training and educational materials 
necessary to provide quality care for and promote respectful dialogue with this population about 
their healthcare needs. Transgender and gender independent patients are not obligated nor should 
they be burdened with providing education to their healthcare providers in order to have their 
healthcare needs be met.  
It is critical that healthcare institutions utilize inclusive documentation methods (i.e., 
intake forms and electronic health records). The use of inclusive intake forms and electronic 
records would allow patients to disclosure their gender identity and/or the manner in which their 
gender identity intersects with their bodies, for clear documentation and dissemination to their 
healthcare teams. Health providers should be aware of and attend to the preferred names, gender 
identity terms, and pronouns (e.g., zir, ze, Mx, he, she, xe, they) that transgender and gender 
independent patients regard as most representative of their identities.  
The health status and/or concerns of transgender and gender independent patients may be 
amalgamated by multiple points of their intersecting identities and may or may not be linearly 
associated with their gender identity. All healthcare institutions, including university and 
community health clinics that provide gender affirming healthcare services (e.g., prescribing 
and/or managing hormone replacement therapies) to transgender and gender independent patients 
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must not neglect the other healthcare needs of these patients. Engaging transgender and gender 
independent patients in a manner that encompasses integrated healthcare services may be 
supportive of an increase in their healthcare utilization and better health outcomes as seen in 
other patient populations (Martin et al., 2014).  
Affordability must also be considered when attempting to address accessibility disparities 
in healthcare faced by this population. Healthcare institutions must not neglect the healthcare 
needs of uninsured or underinsured transgender and gender independent patients, and consider 
their vulnerability to employment and healthcare insurance discrimination. The implementation 
of confidential processes by which transgender and independent patients can report their 
healthcare experiences is an important step in healthcare institutions accepting the obligation to 
ensure that healthcare is accessible to these patients. It is imperative that this population’s 
healthcare experiences are captured, including those experiences that may be facilitative of 
healthcare utilization and avoidance to inform prevention and intervention methods. 
Collaborative and coordinated action within and outside of healthcare institutions is required to 
ameliorate the healthcare accessibility barriers (e.g., economic inequities, discrimination, and 
erasure) that are extraordinarily onerous for the transgender and gender independent population.  
Implication for Policy 
Individual, societal, and institutional bias, stigma, and discrimination persist due to the 
existence of policies that restrict transgender and gender independent individuals’ rights, 
including their right to access healthcare. The findings of this study provide evidence for the 
imperativeness of legislating healthcare policy protections and repealing the policies that 
sanction the erasure and discrimination that transgender and gender independent individuals are 
exposed to in healthcare settings. The U.S. Supreme Court recently ruled that employers cannot 
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fire transgender and gender independent individuals based on their gender identity (U.S. Equal 
Opportunity Commission, 2020). Still, this population remains vulnerable to local, state, and 
federal legislative and regulatory aggressions that further stigmatize, criminalize, delegitimize, 
and dehumanize the embodiment of a transgender and gender independent identity. 
According to the American Civil Liberties Union (ACLU; 2021), dozens of states will 
introduce legislation seeking to prohibit and restrict rights and protections for transgender and 
gender independent citizens before the end of 2021. Legislatures are also seeking to advance 
religious rights and protections for individuals, schools, and healthcare institutions to be 
discriminatory based on gender identity (ACLU, 2021). These religious exemption bills have the 
potential to exacerbate the harmful impacts of the healthcare avoidance behaviors exhibited by 
this population, as Catholic and other religious healthcare institutions are prominent in U.S. 
healthcare.  
This study makes clear the prevalence of denial of gender affirming care at varying 
developmental stages, with 21.4% of the participants reporting that they experienced this form of 
healthcare discrimination at least once in their lifetime, and 9.1% reporting that they had been 
denied gender affirming care before age 18. These findings are consistent with the current 
proposals of legislation being advanced and/or passed to prohibit healthcare for transgender and 
gender independent youth (ACLU, 2021). The Alabama Senate recently passed the “Vulnerable 
Child Compassion and Protection Act” (i.e., Alabama Senate Bill 10), which would prohibit 
transgender and gender independent youth from receiving gender affirming care if passed by the 
Alabama House of Representatives committee on Health and signed by the governor – Kay Ivey 
(ACLU, 2021).  
 57 
Policies that make explicit the illegality of healthcare discrimination in all of its forms 
(including denial of care) must be enacted to ensure that this population is not physically or 
psychologically harmed further by the inaccessibility and underutilization of healthcare 
associated with discrimination and erasure. This study provides evidence of the informational 
and institutional erasure that transgender and gender independent healthcare consumers are 
exposed to, as 64.9% of this sample reported that medical intake forms were not inclusive of 
their gender identities. Robust policy must be enacted to require local, state, and federal 
healthcare institutions and organizations to capture the intersecting identities of transgender and 
gender independent healthcare consumers, and to respond to their healthcare needs. Healthcare 
institutions and organizations whose research and operations are partially or fully funded by 
public funds should be obligated to identify health risks, outcomes, and disparities associated 
with transgender and gender independent constituents. The deficit of local, state, and federal 
policy protections regarding transgender and gender independent healthcare provides a gateway 
for proposed legislation to be distinctly reflective of the healthcare needs of the transgender and 
gender independent community.  
Limitations and Implication for Future Research 
 While this study may elucidate the chronicity of the indiscriminate forms of lifetime 
healthcare discrimination experienced by this population and its harmful associations with  
healthcare avoidance behaviors and psychological distress, there were limitations that must be 
considered. This study utilized a cross-sectional survey design, which did not allow for causal 
inferences. Longitudinal cohort studies should be employed to expand knowledge regarding: (a) 
transgender and gender independent identity development and healthcare accessibility barriers, 
and/or facilitators; (b) relationships that might exist between facilitators and/or barriers to 
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healthcare accessibility and health behaviors, and outcomes across varied developmental stages. 
This study used an online and non-probability sampling method, thereby lessoning its 
representativeness of the diversity that exists among the transgender and gender independent 
population, despite its geographical representativeness of the U.S; the most marginalized tier 
(e.g., those who are most economically vulnerable) of this population were unable to be 
accessed. However, this study was able to capture the experiences of transgender and 
independent individuals in a manner that sought to minimize the potential coronavirus exposure 
and potential anxiety symptoms experienced by participants that might be associated with fear of 
further stigmatization and discrimination associated with their gender identity status. Future 
studies should strive to utilize probability sampling to support: (a) generalizability of the results 
to the full spectrum of identities held within this population; (b) exploration of other social 
identity factors that may contribute to healthcare accessibility, avoidance, and outcomes in this 
population. While this study was able to capture the prevalence of healthcare discrimination and 
healthcare avoidance behaviors associated with the discrimination faced in healthcare settings by 
this population, it did not investigate discriminatory experiences with and avoidance of distinct 
types of healthcare settings/providers (e.g., gynecology, oncology, endocrinology, psychology). 
Future studies should engage transgender and gender independent individuals in quantitative and 
qualitative inquiries about their exposure to and avoidance of distinct forms of erasure and 
discrimination within specific divisions of healthcare. This study garnered information about 
participants intersecting identities with disabilities/neurodivergence and found it to be a predictor 
of healthcare avoidance, but did not inquire about participant diagnoses of specific chronic 
mental and/or physical health conditions. Future research should evaluate distinct health 
conditions as potential moderators of the relationship between healthcare discrimination and 
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utilization in this population. Healthcare discrimination was found to be a significant predictor of 
anxiety symptoms among this sample. However, this study did not investigate the potentiality for 
an association between anxiety with healthcare avoidance behaviors and/or distrust in healthcare 
institutions in this population. Knowledge about the varying facilitators and/or barriers to 
utilization or underutilization of healthcare would be supportive of future research encompassing 
controlled trial experiments regarding the efficacy of healthcare interventions to address the poor 
healthcare outcomes seen in this population.  
Conclusion 
 Notwithstanding these limitations, this study provides information that is critical to 
understanding the health behaviors and subsequent health implications for the transgender and 
gender independent population. This study provides evidence of the persistence of myriad 
institutional, structural, and ideological barriers to this population’s ability to access healthcare 
with associations of deleterious health behaviors (e.g., avoidance) generally and amidst a global 
pandemic, and psychological distress. This study has various applied implications for healthcare 
institutions, providers, researchers, legislators, and LGBTQ+ community organizations in the 
advancement of targeted intervention strategies (e.g., institutional, clinical, and policy) to 
mitigate health disparities in this population. Future research directions should include further 
exploration into the specific barriers (e.g., erasure themes) and facilitators (e.g., access to 
integrated healthcare) of healthcare utilization at various stages throughout the transgender and 
gender independent individual’s lifespan.  
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RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM 
 
STUDY TITLE: Discrimination and Health in Gender Minority Individuals 
 
VCU INVESTIGATOR: Eric Benotsch, Ph.D. 
 
You are being invited to participate in a research study.  
 
Your participation is voluntary. You may decide not to participate in this study. If you do 
participate, you may withdraw from the study at any time. Your decision not to take part or to 
withdraw will involve no penalty. You may print out a copy of this sheet to keep. 
 
Why is this study being done? 
 
The purpose of this research study is to learn more about discrimination experiences and health 
behaviors in gender minority individuals. 
 
 
What will happen if I participate? 
 
In this study you will be asked to complete a questionnaire.  The questionnaire asks about 
discrimination experiences, resiliency factors, stress, loneliness, psychiatric symptoms, substance 
use, use of health care services, and demographic information.  Additional questions will ask 
about the impact the coronavirus (COVID-19) pandemic has had on your life.  There are also 
questions that check if you are paying attention.  You will need to answer these questions 
correctly to receive payment. 
 
The survey will take about 10 minutes to complete. 
 
What are the risks and benefits of participating? 
 
Sometimes answering questions about these subjects causes people to become upset. Some 
questions will ask about private things like substance use. You do not have to answer any 
questions you do not want to answer and you may leave the study at any time. Participation in 
research might involve some loss of privacy. We will not ask your name or any other 
information that will identify you, but there is a small risk that someone outside the research 





WILL I BE PAID TO PARTICIPATE IN THE STUDY? 
 
You will be paid $1.20 to participate in the study. 
 
CAN I STOP BEING IN THE STUDY? 
 
You can stop being in this research study at any time. 
 
HOW WILL INFORMATION ABOUT ME BE PROTECTED? 
 
VCU has established secure research databases and computer systems to store information and to 
help with monitoring and oversight of research. Your information may be kept in these databases 
but are only accessible to individuals working on this study or authorized individuals who have 
access for specific research related tasks.  
 




If you have general questions about your rights as a participant in this or any other research, or if 
you wish to discuss problems, concerns or questions, to obtain information, or to offer input 
about research, you may contact: 
Virginia Commonwealth University Office of Research 
800 East Leigh Street, Suite 3000, Box 980568, Richmond, VA 23298 
(804) 827-2157; https://research.vcu.edu/human_research/volunteers.htm  
 
Do not consent unless you have had a chance to ask questions and have received satisfactory 
answers to all of your questions.  
 
Please indicate if you consent to participate: 
 
_I consent and wish to take part in the study. 
_I do NOT consent and wish to withdraw 
 
 
The investigator named below is the best person(s) to contact if you have any questions, 
complaints, or concerns about your participation in this research: 
 

















I feel part of a community of 
people who share my gender 
identity. 
0 1 2 3 4 
I feel connected to other people 
who share my gender identity. 
0 1 2 3 4 
When interacting with 
members of the community 
who share my gender identity, I 
feel like I belong. 
0 1 2 3 4 
I’m not like other people who 
share my gender identity. 
0 1 2 3 4 
I feel isolated and separate 
from other people who share 
my gender identity. 
0 1 2 3 4 
Please select neither agree nor 
disagree for this item. 
0 1 2 3 4 
 
Testa et al, 2015. (Community Connectedness subscale of Gender Minority Stress and 
Resilience Measure).   
 
Derogatis, 2001 (Depression and Anxiety subscales of Brief Symptom Inventory) 
Please check the number of the response that best describes how much that problem has 
bothered you in the past 7 days, including today: 
In the past 7 days, how much 
were you distressed by:   
Not at all A little bit Moderately Quite a bit Extremely 
Feeling no interest in things 0 1 2 3 4 
Nervousness or shaking inside 0 1 2 3 4 
Feeling lonely 0 1 2 3 4 
Feeling tense or keyed up 0 1 2 3 4 
Feeling blue 0 1 2 3 4 
Suddenly scared for no reason 0 1 2 3 4 
Feelings of worthlessness 0 1 2 3 4 
Spells of terror or panic 0 1 2 3 4 
Feeling hopeless about the future 0 1 2 3 4 
Feeling so restless you couldn’t sit 
still 
0 1 2 3 4 
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Please select “a little bit” for this 
item. 
0 1 2 3 4 
Thoughts of ending your life 0 1 2 3 4 
Feeling fearful 0 1 2 3 4 
 
Hays & DiMatteo, 1987. (8-item UCLA loneliness scale) 
Please indicate how often you feel the way described in each of the following statements: 
 
 Never Rarely Sometimes Often 
I lack companionship. Never Rarely Sometimes Often 
There is no one I can turn to. Never Rarely Sometimes Often 
I am an outgoing person. Never Rarely Sometimes Often 
I feel left out. Never Rarely Sometimes Often 
I feel isolated from others. Never Rarely Sometimes Often 
I can find companionship when I 
want it. 
Never Rarely Sometimes Often 
I am unhappy being so withdrawn. Never Rarely Sometimes Often 
People are around me but not with 
me. 




The questions in this scale ask about your feelings and thoughts during THE LAST 
MONTH.  In each case, please indicate by checking HOW OFTEN you felt or thought a 
certain way. (Cohen & Williamson, 1988. Perceived Stress Scale - 4) 
 






In the last month, how often have you felt that you 
were unable to control the important things in your 
life? 
0 1 2 3 4 
In the last month, how often have you felt 
confident about your ability to handle your 
personal problems? 
0 1 2 3 4 
In the last month, how often have you felt things 
were going your way? 
0 1 2 3 4 
In the last month, how often have you felt 
difficulties were piling up so high that you could 
not overcome them? 








Benotsch et al, 2013, 2015 
Please indicate how much you have used the following in the past 3 months: 
 
 None Once or Twice Several Times At least every 
week 
Alcohol 1 2 3 4 
Cigarettes/Cigars 1 2 3 4 
E-cigarettes/Juul/E-
vaporizor 
1 2 3 4 
Marijuana/Cannabis/Pot 1 2 3 4 
Ecstasy 1 2 3 4 
Methamphetamine 1 2 3 4 
Cocaine (powder or 
crack) 
1 2 3 4 
Club drugs (e.g., 
Ketamine/”Special K”,  
Poppers/”Rush”, GHB,  
Rohypnol/”roofies”)                      
1 2 3 4 
Heroin 1 2 3 4 
Any other recreational 
drugs (list) 
___________________ 





















Miech et al., 2018 (Items adapted from Monitoring the Future study) 
 
To "vape" is to use a device such as a vape-pen, an e-cigarette, an e-hookah, or e-vaporizer to 
inhale a mist into the lungs. Have you ever vaped, even once in your lifetime? 
 
Yes No 
(If no, skip the rest of the questions on this page) 
(If Yes) 
 
On how many occasions (if any) have you vaped NICOTINE in your lifetime? 
 
0 Occasions 1-2 Occasions  3-5 Occasions  6-9 Occasions  10-19 Occasions  
20-39 Occasions  40 or More Occasions 
 
On how many occasions (if any) have you vaped MARIJUANA in your lifetime? 
 
0 Occasions 1-2 Occasions            3-5 Occasions             6-9 Occasions  10-19 Occasions  
20-39 Occasions  40 or More Occasions 
 
On how many occasions (if any) have you vaped NICOTINE during the last 3 months? 
 
0 Occasions 1-2 Occasions  3-5 Occasions 6-9 Occasions  10-19 Occasions  
20-39 Occasions  40 or More Occasions 
 
On how many occasions (if any) have you vaped MARIJUANA during the last 3 months? 
 
0 Occasions 1-2 Occasions  3-5 Occasions 6-9 Occasions  10-19 Occasions  




















Benotsch et al, 2013, 2015 
In your lifetime, have you ever used a prescription medication (e.g., Vicodin, Xanax) 
WITHOUT a doctor’s prescription?         
    
Yes       No   




Please indicate how much you have used the following in the past 3 months: 
 
 None Once or Twice Several Times At least every 
week 




WITHOUT a doctor’s 
prescription 
1 2 3 4 
Sedatives (e.g., 
Restoril, Ambien)  
WITHOUT a doctor’s 
prescription 
1 2 3 4 
Anxiety Medications  
(e.g., Xanax, Valium) 
WITHOUT a doctor’s 
prescription 
1 2 3 4 
Stimulants (e.g., 
Ritalin, Adderall) 
WITHOUT a doctor’s 
prescription 
1 2 3 4 
 
In your lifetime, have you ever used alcohol at the same time as prescription medication used 
without a doctor’s prescription?            
Yes 
 No  
        
In your lifetime, have you ever used recreational drugs (e.g., ecstasy, cocaine) at the same time 
as prescription medication used without a doctor’s prescription?         






On March 11, 2020, the World Health Organization declared that the coronavirus (COVID-19) 
outbreak had reached pandemic status.  Since the start of the coronavirus pandemic, has the 




(If Yes) How has your use of substances changed since the start of the coronavirus pandemic? 
It has increased a lot 
It has increased somewhat 
It has increased slightly 
It has decreased slightly 
It has decreased somewhat 
It has decreased a lot 
 
In this section gender expression means how masculine/feminine/androgynous one appears 
to the world based on many factors such as mannerisms, dress, personality, etc.  Testa et al, 
2015. 
 
Please check all that apply (for example you may check both “yes, after age 18” and “in the 
past year” if both are true for you). 







I have had difficulty getting 
medical or mental health treatment 
(transition-related or other) 
because of my gender identity or 
expression. 
    
Because of my gender identity or 
expression, I have had difficulty 
finding a bathroom to use when I 
am out in public. 
    
I have experienced difficulty 
getting identity documents that 
match my gender identity. 
    
I have had difficulty finding 
housing or staying in housing 
because of my gender identity or 
expression. 
    
I have had difficulty finding 
employment or keeping 
employment, or have been denied 
promotion because of my gender 
identity or expression. 
    
(Gender-Related Discrimination subscale of Gender Minority Stress and Resilience 
Measure).   
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The next section asks some additional questions about the coronavirus (COVID-19) pandemic. 
(Wang et al., 2020) 
Where do you receive information about COVID-19? Check all that apply 
o Television 
o Online News Media 
o Social Media 
o Government website 
o Family or friends 
o Other sources (please specify) 
 
How often do you receive information on COVID-19? 
• Less than once a week 
• Multiple times a week 
• Daily 
• Multiple times a day 
 
(If selected “social media” in first question on this page).   
 
How often do you see memes that have health information about COVID-19 in them? 
• Less than once a week 
• Multiple times a week 
• Daily 
• Multiple times a day 
 
How satisfied are you with the amount of health information available about the coronavirus 
(COVID-19)? 
1. Not satisfied at all 
2. Not very satisfied 
3. Somewhat satisfied 
4. Very satisfied 
5. Do not know 
 




(If No, ask next two questions) 
 
Have you had symptoms that might have been the coronavirus (COVID-19) such as fever, 







How would you rate your likelihood of contracting the coronavirus (COVID-19) during the 
current outbreak? 
1. Not at all likely 
2. Not very likely 
3. Somewhat likely 
4. Very likely 
5. Do not know 
 
Adapted from Coronavirus Anxiety Scale (CAS) Lee, S. A. (2020). Coronavirus anxiety scale: A 
brief mental health screener for COVID-19 related anxiety. Death Studies, 1-9. 
 
How often have you experienced the 









I felt dizzy, lightheaded or faint, when I 
read or listened to news about the 
coronavirus. 
0 1 2 3 4 
I had trouble falling or staying asleep 
because I was thinking about the 
coronavirus. 
0 1 2 3 4 
I felt paralyzed or frozen when I thought 
about or was exposed to information 
about the coronavirus. 
0 1 2 3 4 
Please select “a little bit” for this item. 0 1 2 3 4 
I used alcohol or other drugs to help me 
get through the fear and/or anxiety 
caused by the coronavirus. 




To date, about how many people have died due to the coronavirus (COVID-19) in the United 
States?  
 
Please provide your best estimate:     
 
 




 Some of the time 
 Most of the time 





In the last month, how much have you engaged in social / physical distancing? 
 
 None 
 Some of the time 
 Most of the time 
 All of the time 
 
Have any of these things happened to you, as a trans / gender non-conforming person, when you 
went to see a doctor or health care provider?  Please check all that apply (for example you 
may check both “yes, after age 18” and “in the past year” if both are true for you). (Items 
adapted from 2015 Transgender Survey. James et al. (2016).) 




Yes, in the 
past year 
I had to teach a doctor or other 
health care provider about 
trans/gender non-conforming 
people so that I could get 
appropriate care. 
    
A doctor or other health care 
provider refused to give me 
trans/gender non-conforming-
related care. 
    
A doctor or other health care 
provider refused to give me other 
health care (such as physical exam, 
flu, diabetes). 
    
A doctor asked me 
unnecessary/invasive questions 
about my trans/gender non-
conforming status that were not 
related to the reason for my visit. 
    
A doctor or other health care 
provider used harsh or abusive 
language when treating me. 
    
I was verbally harassed in a health 
care setting (such as hospital, 
office, clinic). 
    
A doctor or other health care 
provider refused to use the 
pronouns or name that I requested 
to be used. 
    
The medical forms or documents 
that a doctor or other health care 
provider asked me to complete did 
not include my gender identity. 
    
 
 82 
Was there a time in the past 12 months when you needed to see a doctor but could not because 





Was there a time in the past 12 months when you needed to see a doctor but did not because you 




Since the start of the coronavirus pandemic (3/11/20), was there a time when you needed to 




Was there a time since the start of the coronavirus pandemic when you needed to see a doctor 
but did not because you thought you would be disrespected or mistreated as a trans/gender non-




Was there a time since the start of the coronavirus pandemic, when you needed to see a doctor 






















What is your age? ___________ years  
   
What was your sex identified at birth?  Male  Female 
 
How do you identify your gender now?  Man   (Check all that apply) 
Woman      
Trans Man      
Trans Woman 
Non-binary 
Genderqueer    
Gender non-conforming 
Gender fluid     
Another identity not listed______________ 
 
What state do you live in?  (drop-down menu of states): 
 
 
Which best describes you? (check all that apply) 
Black/African-American      
Asian/Asian-American      
Hispanic/Latino(a)      
Native American        
White      
Another identity not listed___________ 
 
 








Graduate Degree (Master’s, Doctorate, etc.) 
 
 
What is your employment status?  (check all that apply) 
 
 Employed full time 
 Employed part time 
 Student 
 Retired 
 On disability 
 Unemployed 
 Other____________  
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(If Yes) How has your employment situation changed since the coronavirus pandemic? (check 
all that apply) 
 Lost my job 
 Had my hours and/or pay reduced 
 Had my hours and/or pay increased 
 Was previously unemployed but now have a job 
 I am now working remotely 
 Other__________________ 
In the past year where have you primarily lived?  
University housing  
Alone in Non-University housing  
With my partner 
With friends / roommates 
With my parents / siblings 
In a shelter or experiencing housing instability 
Another housing/living arrangement not listed________ 





Since the start of the coronavirus pandemic where have you primarily lived? 
University housing  
Alone in Non-University housing  
With my partner 
With friends / roommates 
With my parents / siblings 
In a shelter or experiencing housing instability 








Which best describes you? 
 
Heterosexual/Straight     
Homosexual/Gay    
Bisexual     
Pansexual 
Asexual   
Another identity not listed_________ 
 
To what degree are you open (out) with your transgender identity in your personal / social life 
including with friends and family? 






7 All of the time 
 
To what degree are you open (out) with your transgender identity in your work / professional life 
including with coworkers or classmates? 






7 All of the time 









What type of health insurance do you have? 
 
Private Insurance (Includes: Plans through employers, federal employee plans, plans from the 
Marketplace, plans through parents or partners, plans through universities)   
 




Are any of your daily activities limited in any way because of your physical, mental, or 






Do you use any assistive equipment or technologies, such as a mobility device, a wheelchair, a 












What is your household annual income? 
 
__ $0 - $20,000 
__ $20,001 - $40,000 
__ $40,001 - $60,000 
__ $60,001 - $80,000 
__ $80,001 - $100,000 
__ More than $100,000 
 
 
Please let us know if you have any feedback about this study.  If you do not have feedback, you 
can skip this question and click the following link to be redirected back to the Prolific site. 
______________________________________________________________________________ 
 
